Serum Albumin Still of Interest to Predict Outcomes in Membranous Nephropathy in the Era of Phospholipase A2 Receptor
Marion Delafosse,
Eléonore Ponlot,
Nicolas Hanset,
Emmanuel Estève,
Jean-Jaques Boffa,
Karine Dahan
Affiliations
Marion Delafosse
Department of Nephrology, Tenon Hospital, Paris, France; Sorbonne Université, Institut national de la santé et de la recherche médicale (National Institute of Health and Medical Research in France) UMRS 1155, Tenon Hospital, Paris, France
Eléonore Ponlot
Department of Nephrology, Tenon Hospital, Paris, France
Nicolas Hanset
Department of Nephrology, Tenon Hospital, Paris, France
Emmanuel Estève
Department of Nephrology, Tenon Hospital, Paris, France; Sorbonne Université, Institut national de la santé et de la recherche médicale (National Institute of Health and Medical Research in France) UMRS 1155, Tenon Hospital, Paris, France
Jean-Jaques Boffa
Department of Nephrology, Tenon Hospital, Paris, France; Sorbonne Université, Institut national de la santé et de la recherche médicale (National Institute of Health and Medical Research in France) UMRS 1155, Tenon Hospital, Paris, France
Karine Dahan
Department of Nephrology, Tenon Hospital, Paris, France; ANDRA, B Braun Avitum, Paris, France; Correspondence: Karine Dahan, Department of Nephrology, Tenon Hospital, 75020, Paris, France.
